CITI/CALL/CSPC PHARMACEUTICAL GROUP/7.7/0.2/21.11.24 | Market Closed - Hong Kong S.E. 01:30:00 21/05/2024 pm IST | ||
| 0.074 HKD | -15.91% |
|
| Current month | -7.50% | ||
| 1 month | +72.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about CSPC PHARMACEUTICAL GROUP LTD.
More news
| Date | Price | Change |
|---|---|---|
| 21/24/21 | 0.074 | -15.91% |
| 20/24/20 | 0.088 | +14.29% |
| 17/24/17 | 0.077 | -3.75% |
| 16/24/16 | 0.08 | -5.88% |
| 14/24/14 | 0.085 | -15.00% |
Delayed Quote Hong Kong S.E.
Last update May 21, 2024 at 01:30 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | CSPC PHARMACEUTICAL GROUP LTD. |
| Issuer | 
Citi
|
| ISIN | DE000KH6GZ30 |
| Date issued | 12/07/2023 |
| Strike | 7.7 $ |
| Maturity | 21/11/2024 (184 Days) |
| Parity | 5 : 1 |
| Emission price | 0.25 $ |
| Emission volume | N/A |
| Settlement | cash |
| Currency | HKD |
Technical Indicators
| Highest since issue | 0.248 $ |
|---|---|
| Lowest since issue | 0.043 $ |
| Spread | 0.002 $ |
| Spread % | 2.67% |
Company Profile
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
-
Ratings for CSPC Pharmaceutical Group Ltd.
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: CSPC Pharmaceutical Group Ltd.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
6.57
HKD
Average target price
9.382
HKD
Spread / Average Target
+42.80%
- Stock Market
- Warrants
- Warrant
